Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Assumptions Used to Determine Grant-date Fair Value of Stock Options Granted

The following table presents, on a weighted-average basis, the assumptions used in the Black-Scholes option pricing model to determine the grant-date fair value of stock options granted:

	Year Ended December 31,
	2024			2023
Fair value of common stock	$	13.08		$	8.51
Risk-free interest rate		4.09	%		3.06	%
Expected term (in years)		6.02			5.39
Expected volatility		86.80	%		75.12	%
Expected dividend yield		0	%		0	%

Summary of Stock Options Activity

						Weighted-
				Weighted- Average		Average Remaining		Aggregate
	Number of Options			Exercise Price		Contractual Term		Intrinsic Value
						(in years)		(in thousands)
Outstanding at December 31, 2023		5,202,905		$	6.30		8.1	$	535
Granted		935,105		$	9.27
Exercised		(11,953	)	$	7.42
Forfeited or cancelled		(415,087	)	$	8.96
Expired		(43,415	)	$	7.58
Outstanding at December 31, 2024		5,667,555		$	6.98		7.6	$	22,962
Vested and expected to vest at    December 31, 2024		5,667,555		$	6.98		7.6	$	22,962
Options exercisable at December 31, 2024		2,887,678		$	6.88		6.6	$	12,174

Summary of Non-Vested Stock Options

The following table summarizes the non-vested stock options that were outstanding as of December 31, 2024 and 2023:

			Weighted- Average
	Number of Options		Exercise Price
Non-vested options, December 31, 2024		2,779,877	$	7.07
Non-vested options, December 31, 2023		3,124,193	$	6.06

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense related to the stock options was included in the Company’s statements of operations and comprehensive loss as follows:

	Year Ended December 31,
	2024		2023
	(in thousands)
Cost of sales	$	275	$	239
Research and development		1,144		1,781
Sales and marketing		1,661		610
General and administrative		3,304		3,028
Total stock-based compensation expense	$	6,384	$	5,658